Ajinomoto Cambrooke Metabolic Nutrition Revenue and Competitors

Ayer, MA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Ajinomoto Cambrooke Metabolic Nutrition's estimated annual revenue is currently $13.3M per year.(i)
  • Ajinomoto Cambrooke Metabolic Nutrition's estimated revenue per employee is $135,714

Employee Data

  • Ajinomoto Cambrooke Metabolic Nutrition has 98 Employees.(i)
  • Ajinomoto Cambrooke Metabolic Nutrition grew their employee count by 14% last year.

Ajinomoto Cambrooke Metabolic Nutrition's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
VP & Corporate OfficerReveal Email/Phone
3
ControllerReveal Email/Phone
4
VP operationsReveal Email/Phone
5
Director Corporate Strategy and Digital TransformationReveal Email/Phone
6
Associate Director - Safety, Environmental, and QualityReveal Email/Phone
7
Human Resources DirectorReveal Email/Phone
8
Director Product DevelopmentReveal Email/Phone
9
Director Medical NutritionReveal Email/Phone
10
Corporate Marketing Director and LeaderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.3M8813%N/AN/A
#2
$1.2M6-54%N/AN/A
#3
$5.3M50-26%$29.3MN/A
#4
$24.7M164-5%$45.2MN/A
#5
$4.8M6124%N/AN/A
#6
$77M0N/A$866MN/A
#7
$0.3M4-33%N/AN/A
#8
$3.9M3525%N/AN/A
#9
$234.6M119610%N/AN/A
#10
$18.6M133-16%$23.3MN/A
Add Company

What Is Ajinomoto Cambrooke Metabolic Nutrition?

Ajinomoto Cambrooke, Inc. formerly Cambrooke Therapeutics, Inc. (expansion of Cambrooke Foods) was founded in 2000 by Lynn and David Paolella, the parents of two children diagnosed with a rare disease called phenylketonuria (PKU). PKU is one of the few genetic diseases, which is managed almost entirely with nutritional intervention. The Paolellas' goal in forming Cambrooke was simple - to develop improved nutritional therapeutic options for those with serious medical disorders. Today, Cambrooke produces medical formulas and foods for the management of a variety of medical conditions and we are continually innovating new nutritional options targeted at a wide array of diseases. Ajinomoto Cambrooke, Inc. - Leaders in Therapeutic Medical Nutrition. Cambrooke was the first medical foods company to launch a natural intact protein for the dietary management of phenylketonuria called Glytactinâ„¢ (modified glycomacropeptide). Cambrooke collaborates with academia and industry partners to transform early phase development projects in therapeutic nutrition into viable commercial products. Cambrooke employs scientific experts in the development, manufacturing and commercialization of nutritional therapeutics for patients with rare diseases. Cambrooke's products are supported by clinical evidence for the nutritional management of medical needs before they are selected for commercialization. Cambrooke believes that both large and small patient populations are important when it comes to complex nutritional requirements.

keywords:N/A

N/A

Total Funding

98

Number of Employees

$13.3M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$52.6M122-11%N/A
#2
$36.7M1368%N/A
#3
$98.1M398-1%$90M